TBA-7371

DRUG2 trials

Sponsors

Global Alliance for TB Drug Development, Gates Medical Research Institute

Conditions

Pulmonary TuberculosisTuberculosisTuberculosis, Pulmonary

Phase 1

A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371

CompletedNCT03199339

Global Alliance for TB Drug DevelopmentTuberculosis, Tuberculosis, Pulmonary

Start: 2017-08-29End: 2018-07-08Updated: 2018-10-17

Phase 2

Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

CompletedNCT04176250

Gates Medical Research InstitutePulmonary Tuberculosis

Start: 2020-01-16End: 2022-10-05Updated: 2024-04-11